Figure 1 - uploaded by An R. Van Rompay
Content may be subject to copyright.
Osteopontin (OPN) immunostaining of human kidney tissue from implantation biopsies, using a peroxidase-diaminobenzidine procedure. Tissue sections were counterstained with periodic acid-Schiff reagent. Distal tubular cells (DTC) exhibited pronounced apical OPN immunostaining (black arrows); however, some DTC also exhibited OPN signals in perinuclear vesicles (white arrow). Slightly damaged proximal tubular cells (PTC) demonstrated perinuclear OPN staining (arrowheads). Magnification, ϫ 400. 

Osteopontin (OPN) immunostaining of human kidney tissue from implantation biopsies, using a peroxidase-diaminobenzidine procedure. Tissue sections were counterstained with periodic acid-Schiff reagent. Distal tubular cells (DTC) exhibited pronounced apical OPN immunostaining (black arrows); however, some DTC also exhibited OPN signals in perinuclear vesicles (white arrow). Slightly damaged proximal tubular cells (PTC) demonstrated perinuclear OPN staining (arrowheads). Magnification, ϫ 400. 

Source publication
Article
Full-text available
In normal human and rat kidneys, osteopontin (OPN) is present at the apical surface of cells in the distal nephron. After ischemic or toxic renal damage in rats, OPN is upregulated in distal tubular cells (DTC) and expressed de novo in perinuclear vesicles in proximal tubular cells (PTC). In the first phase of this study, OPN localization in ischem...

Context in source publication

Context 1
... is present at the apical surface of cells in the distal nephron. After ischemic or toxic renal damage in rats, OPN is upregulated in distal tubular cells (DTC) and expressed de novo in perinuclear vesicles in proximal tubular cells (PTC). In the first phase of this study, OPN localization in ischemic human biopsies was compared with that in ischemic rat kidneys. In the second phase, cultures of PTC and DTC were used to investigate human renal OPN synthesis, secretion, and localization. OPN localization in human biopsies after renal ischemia was comparable to that in ischemic rat kidneys. Microscopic and flow cytometric detection of immunofluorescent OPN staining in tubular cell cultures demonstrated strong plasma membrane localization in DTC, whereas mainly perinuclear intracellular expression was observed in PTC. Northern blotting and reverse transcription-PCR demonstrated production of a single OPN Osteopontin (OPN) is a glycosylated phosphoprotein that was originally isolated from bone (1) but is expressed in a variety of tissues, including renal tubular epithelium (2– 4). In normal human and rat kidneys, OPN expression is mainly confined to the apical cell surface of a few cells in Henle’s loop and in the more distal parts of the nephron (2,3,5,6). Constitutive OPN expression is thought to play a role in the process of nephrolithiasis (7–9). In several experimental models of renal disease, highly upregulated OPN levels have been reported (5,6,10 –16). The precise role of OPN in renal pathophysiologic processes re- mains unclear, however. A protective role for OPN was de- duced from its ability to reduce inducible nitric oxide synthase levels (17,18). Through its interactions with several integrins, OPN has been reported to promote cell attachment and migra- tion (19,20) and to decrease tubular cast formation (21). The stimulation of transforming growth factor- ␤ activity, collagen deposition (22), and macrophage attraction (22,23) and the reduction of apoptotic cell death (22) suggest a role for OPN in renal fibrosis. mRNA in PTC and DTC. Detection of OPN by Western blotting and enzyme-linked immunosorbent assay demonstrated that PTC and DTC synthesized and secreted the same three molecular mass OPN forms, in comparable amounts. Finally, confocal microscopy demonstrated different staining patterns for endocytotic/lysosomal vesicles and perinuclear OPN; however, perinuclear OPN exhibited colocalization with the Golgi apparatus. In conclusion, human renal OPN localization in cell cultures demonstrated differences between PTC and DTC comparable to those observed after renal ischemia in vivo . Therefore, these cell cultures represented an excellent model for the study of human OPN synthesis, secretion, and localization in PTC versus DTC. It is reported for the first time that intracellular OPN is located in the Golgi apparatus of both PTC and DTC and that PTC and DTC are able to produce and secrete the same OPN isoforms, in comparable amounts. Upregulated OPN expression after acute renal injury in rats exhibits a specific pattern (5,6). Distal tubular cells (DTC) demonstrate pronounced OPN expression at their apical cell surfaces, whereas only a few DTC exhibit perinuclear staining. In proximal tubular cells (PTC), however, OPN is predominantly observed in perinuclear vesicles and apical cell surface expression is restricted to regenerating PTC (6). The same pattern of OPN expression, although less prominent, was observed by Hudkins et al. (2) in normal human kidney at sites of interstitial inflammation and fibrosis. An understanding of renal OPN function requires elucida- tion of this peculiar OPN expression pattern. OPN synthesis, secretion, and localization in primary cell cultures of human PTC and DTC were examined, to obtain better insight into the cellular OPN expression pattern and to learn more regarding human OPN expression in general. A cell culture system for mixed and pure human PTC and DTC was previously developed in our laboratory (24 –26). Flow cytometric immunodissection of PTC and DTC, on the basis of their expression of leucine aminopeptidase (LAP) and epithelial membrane antigen (EMA), respectively, has been described as an accurate method to obtain pure primary cultures of human PTC and DTC (24 –26). In the mixed cultures, PTC or DTC origins can be determined by means of LAP or EMA expression, respectively (24 –26). OPN localization was investigated by microscopic and flow cytometric analyses after immunofluorescent staining of cell cultures for OPN, LAP, and EMA. OPN transcription was studied by Northern blotting and reverse transcription (RT)- PCR, and OPN synthesis and secretion were investigated by Western blotting and enzyme-linked immunosorbent assays (ELISA) of both cell culture conditioned media and cell lysates. Intracellular OPN localization was investigated by means of confocal microscopy, using antibodies raised against OPN and specific organelle markers. As presented in Figure 1, pronounced OPN immunoreactivity was present at the apical cell surface of distal tubules. Some DTC also exhibited OPN signals in perinuclear vesicles. In PTC, however, OPN immunostaining was restricted to perinuclear vesicles in slightly damaged tubules. All biopsies were obtained from the cortex; therefore, the proximal tubules are S1/S2 segments. Flow cytometric immunodissection resulted in 97% pure cultures of PTC and DTC. Both mixed and pure tubular cells grew to 90% confluence within approximately 6 d. As noted earlier by Helbert et al. (25), cultures retained exclusive LAP or EMA expression during that period. OPN expression was therefore investigated in primary mixed and pure cultures of PTC and DTC. Because flow cytometric immunodissection resulted into low cell yields, mixed cultures were used when possible. Immunocytochemical analyses clearly demonstrated different OPN expression patterns in DTC and PTC (Figures 2 and 3). In both mixed (Figure 2, A, A', B, and B') and pure (Figure 2, C and D) tubular cultures, virtually all DTC (EMA-positive) demonstrated strong OPN immunoreactivity (Figure 2, A and A'), whereas PTC (LAP-positive) were weakly OPN positive (Figure 2, B and B'). OPN staining of EMA-positive DTC was intense and covered the entire cell surface (consistent with plasma membrane expression) (Figure 2C). Much less plasma membrane staining was observed in LAP-positive PTC (Figure 2D), where OPN staining appeared mainly intracellular and perinuclear. This perinuclear intracellular OPN staining in PTC was clearly demonstrated when cells were permeabilized before immunostain- ing and were observed with confocal laser scanning microscopy (Figure 3). Intracellular perinuclear OPN staining in DTC could be observed only when plasma membrane OPN staining was less prominent (Figure 3). Flow cytometric detection of OPN on living, unfixed, nonpermeable cells confirmed the presence of OPN at the extracellular cell surface (plasma membrane OPN expression). To obtain quantitative data on this plasma membrane expression, we performed a flow cytometric analysis with OPN/LAP/EMA triple-staining. EMA- and LAP-positive populations were de- fined (Figure 4, A and B). Plasma membrane OPN expression was mainly concentrated on EMA-positive DTC (Figure 4C), with much less expression on LAP-positive PTC (Figure 4D). LAP/EMA/OPN staining of three different kidney specimens indicated that 93.3 Ϯ 5.6% of DTC were OPN-positive, whereas only 17.5 Ϯ 15.5% of PTC were OPN-positive; OPN expression on PTC varied considerably among different kidney specimens, whereas OPN expression on DTC was rather con- stant. Furthermore, it could be demonstrated that the OPN fluorescence signal was much stronger in EMA-positive cells. Indeed, the OPN signal of DTC was clearly shifted to the right, compared with the negative control signal (Figure 4C), whereas the OPN fluorescence of PTC was difficult to distin- guish from the negative control signal (Figure 4D). Consequently, the results of microscopic and flow cytometric OPN analyses were in close agreement with each other. Northern blot analysis revealed that tubular cell cultures produced a single OPN mRNA of 1.6 kb (Figure 5). Comparable amounts of this transcript were present in PTC, DTC, and mixed tubular cell cultures. The size of the OPN mRNA produced in human tubular cell cultures agreed with the size of the OPN mRNA in human kidney tissue (data not shown) and with the reported size of the complete OPN cDNA sequence (GenBank accession number AF052124). RT-PCR resulted in one product, with the expected size of 960 bp, in PTC and DTC (data not shown). Sequence analysis revealed that the coding sequences for OPN were identical in PTC and DTC. Therefore, no alternative splicing occurred in PTC or DTC. Western blot analysis demonstrated full-length human recombinant OPN (produced as described in Materials and Methods) as a 58-kD protein (Figure 6). Analysis of urinary OPN revealed 66- and 72-kD protein bands (Figure 6). In conditioned media and cell lysates of mixed PTC and DTC, OPN forms of 66 and 72 kD (equivalent to urinary OPN) and a 58-kD form (equivalent to human recombinant OPN) were identified (Figure 6). Some lower-molecular mass forms were also detected in cell lysates and conditioned media, probably because of protein degradation. No differences were observed between PTC and DTC or between cell lysates and conditioned media. ELISA allowed quantification of OPN production and secretion. Comparable results were observed for PTC and DTC, which produced 7.3 and 6.4 mg OPN/g protein, respectively, of which 7.1 and 5.9 mg OPN/g protein were secreted into the medium. Therefore, no important quantitative differences in the levels of OPN production were observed between PTC and DTC. Uptake of FITC-labeled dextran resulted in a punctuate fluorescence pattern throughout the cell cytoplasm (Figure 7). Lysosomal staining was also scattered throughout the cytoplasm (Figure ...

Citations

... [22] Interestingly, implantation biopsies also showed perinuclear osteopontin staining in the slightly damaged proximal tubular cells (in addition to pronounced apical expression in the distal tubular cells), suggesting that osteopontin expression in proximal tubules may be induced with injury. [24] However, the effect of variation in pre-analytic sources, e.g. diabetes or hypertension, on osteopontin expression require further study. ...
Preprint
Aims/Hypothesis Diabetic kidney disease (DKD) remains a significant cause of morbidity and mortality in people with diabetes. Though animal models have taught us much about the molecular mechanisms of DKD, translating these findings to human disease requires greater knowledge of the molecular changes caused by diabetes in human kidneys. Establishing this knowledge base requires building carefully curated, reliable, and complete repositories of human kidney tissue, as well as tissue proteomics platforms capable of simultaneous, spatially resolved examination of multiple proteins. Methods We used the multiplexed immunofluorescence platform CO-Detection by indexing (CODEX) to image and analyze the expression of 21 proteins in 23 tissue sections from 12 individuals with diabetes and healthy kidneys (DM, 5 individuals), DKD classes IIA, and IIB (2 individuals per class), IIA-B intermediate (2 individuals), and III (one individual). Results Analysis of the 21-plex immunofluorescence images revealed 18 cellular clusters, corresponding to 10 known kidney compartments and cell types, including proximal tubules, distal nephron, podocytes, glomerular endothelial and peritubular capillaries, blood vessels, including endothelial cells and vascular smooth muscle cells, macrophages, cells of the myeloid lineage, broad CD45+ inflammatory cells and the basement membrane. DKD progression was associated with co-localized increase in collagen IV deposition and infiltration of inflammatory cells, as well as loss of native proteins of each nephron segment at variable rates. Compartment-specific cellular changes corroborated this general theme, with compartment-specific variations. Cell type frequency and cell-to-cell adjacency highlighted (statistically) significant increase in inflammatory cells and their adjacency to tubular and αSMA+ cells in DKD kidneys. Finally, DKD progression was marked by substantial regional variability within single tissue sections, as well as variability across patients within the same DKD class. The sizable intra-personal variability in DKD severity impacts pathologic classifications, and the attendant clinical decisions, which are usually based on small tissue biopsies. Conclusions/Interpretations High-plex immunofluorescence images revealed changes in protein expression corresponding to differences in cellular phenotypic composition and microenvironment structure with DKD progression. This initial dataset demonstrates the combined power of curated human kidney tissues, multiplexed immunofluorescence and powerful analysis tools in revealing pathophysiology of human DKD.
... OPN is a glycosylated phosphoprotein that is expressed in several tissues, including the renal tubular epithelium. In the kidney, it is expressed mainly on the apical cell surface in the Environ Sci Pollut Res loop of Henle and the more distal parts of the nephron (Verhulst et al. 2002), and this molecule has been linked to inflammatory, cardiac metabolic, and metabolic processes (Mihai et al. 2019) which has been shown to be a reliable predictor of renal damage. In a study of newborns with low birth weight, it was observed that the urinary concentration of OPN was higher in these newborns with acute renal failure (0.47 μg/mL) compared to healthy children (0.22 μg/mL) (Hwang et al. 1994). ...
Article
Full-text available
Polycyclic aromatic hydrocarbons (PAHs) are environmental persistent chemicals, produced by the incomplete combustion of solid fuels, found in smoke. PAHs are considered carcinogenic, teratogenic, and genotoxic. Children are susceptible to environmental pollutants, particularly those living in high-exposure settings. Therefore, the main objective of this study was to evaluate the exposure to PAHs through hydroxylated metabolites of PAHs (OH-PAHs), 1-hydroxynaphtalene (1-OH-NAP) and 2-hydroxynaphtalene (2-OH-NAP); 2-,3- and 9-hydroxyfluorene (2-OH-FLU, 3-OH-FLU, 9-OH-FLU); 1-,2-,3- and 4-hydroxyphenanthrene (1-OH-PHE, 2-OH-PHE, 3-OH-PHE, 4-OH-PHE) and 1-hydroxypyrene (1-OH-PYR), as well as kidney health through biomarkers of early kidney damage (Osteopontin (OPN), Neutrophil Gelatinase-Associated Lipocalin (NGAL), α1-Microglobulin (α1-MG), and Cystatin C (Cys-C)) in children from an indigenous community dedicated to footwear manufacturing and pottery in Ticul, Yucatán, Mexico. The results show a high exposure to PAHs from the found concentrations of OH-PAHs in urine in 80.5% of the children in median concentrations of 18.4 (5.1-71.0) µg/L of total OH-PAHs, as well as concentrations of kidney damage proteins in 100% of the study population in concentrations of 4.8 (3-12.2) and 7.9 (6.5 - 13.7) µg/g creatinine of NGAL and Cys-C respectively and, 97.5% of the population with concentrations of OPN and α1-MG at mean concentrations of 207.3 (119.8-399.8) and 92.2 (68.5-165.5) µg/g creatinine. The information provided should be considered and addressed by the health authorities to establish continuous biomonitoring and programs to reduce para-occupational exposure in the vulnerable population, particularly children, based on their fundamental human right to health.
... OPN is a glycosylated phosphoprotein expressed in various tissues, including renal tubular epithelium. In the kidney, OPN is expressed mainly on the surface of the apical cell in the loop of Henle as well as in the more distal parts of the nephron (Verhulst et al. 2002); this molecule has been related to inflammatory, cardiac metabolic processes and has also been proposed as a good predictor of chronic kidney disease (CKD) (Fernando et al. 2019;Mihai et al. 2019). In CKD patients, it is a good predictor of incidents at concentrations of 0.113 μg/L (Feldreich et al. 2017). ...
Article
Full-text available
The traditions and habits of indigenous communities in México include the use of wood and biomass burning to cook their food, which generates large amounts of smoke and therefore pollution inside the households. This smoke is composed of a complex mixture of Polycyclic Aromatic Hydrocarbons (PAHs) which at high levels of exposure cause carcinogenic, genotoxic effects and some chronic pulmonary and cardiovascular diseases, however, few studies relate kidney health with exposure to PAHs. Thus, the aim of this study was the evaluation of 10 hydroxylated metabolites of PAHs (OH-PAHs), and their correlation with biomarkers of early kidney damage renal (Cystatin-C (Cys-C)), Osteopontin (OPN), Retinol Binding Protein-4 (RPB-4), and Neutrophil Gelatinase-Associated Lipocalin (NGAL) in the indigenous population of the Huasteca Potosina in Mexico. The results demonstrate the presence of the OH-PAHs and kidney damage biomarkers in 100% of the study population. The OH-PAHs were shown in the following order of frequency, 1-OH-PYR>4-OH-PHE>2-OH-NAP>1-OH-NAP>9-OH-FLU>3-OH-FLU>2-OH-FLU>3-OH-PHE and with the following percentages of detection 97.6, 87.8, 78, 73.2, 68.3, 31.7, 14.6 and 12.2% respectively. NGAL and RBP-4 were present in above 85% of the population, with mean concentrations of 78.5 ± 143.9 and 139.4 ± 131.7 ng/g creatinine respectively, OPN (64%) with a mean concentration of 642.6 ± 723.3 ng/g g creatinine, Cys-C with a mean concentration of 33.72 ± 44.96 ng/ g creatinine. Correlations were found between 1-OH-NAP, 2-OH-NAP, 9-OH-FLU and 4-OH-PHE and the four biomarkers of early kidney damage. 3-OH-FLU with OPN and 1-OH-PYR correlated significantly with NGAL, OPN, and RPB-4.
... The most abundant protein in MSK vesicles was SPP1, also known as osteopontin, which is implicated in physiological/pathological bone mineralization and kidney stone formation [19]. This protein is synthesized in the kidney and secreted into the urine by epithelial cells, including those lining the loop of Henle, distal convoluted tubule, and papillary duct [20]. SPP1 inhibits the nucleation, growth, and aggregation of calcium oxalate crystals [21] and the binding of these crystals to kidney epithelial cells [22]. ...
Article
Full-text available
Medullary sponge kidney (MSK) disease is a rare and neglected kidney condition often associated with nephrocalcinosis/nephrolithiasis and cystic anomalies in the precalyceal ducts. Little is known about the pathogenesis of this disease, so we addressed the knowledge gap using a proteomics approach. The protein content of microvesicles/exosomes isolated from urine of 15 MSK and 15 idiopathic calcium nephrolithiasis (ICN) patients was investigated by mass spectrometry, followed by weighted gene coexpression network analysis, support vector machine (SVM) learning, and partial least squares discriminant analysis (PLS-DA) to select the most discriminative proteins. Proteomic data were verified by ELISA. We identified 2998 proteins in total, 1764 (58.9%) of which were present in both vesicle types in both diseases. Among the MSK samples, only 65 (2.2%) and 137 (4.6%) proteins were exclusively found in the microvesicles and exosomes, respectively. Similarly, among the ICN samples, only 75 (2.5%) and 94 (3.1%) proteins were exclusively found in the microvesicles and exosomes, respectively. SVM learning and PLS-DA revealed a core panel of 20 proteins that distinguished extracellular vesicles representing each clinical condition with an accuracy of 100%. Among them, three exosome proteins involved in the lectin complement pathway maximized the discrimination between MSK and ICN: Ficolin 1, Mannan-binding lectin serine protease 2, and Complement component 4-binding protein β. ELISA confirmed the proteomic results. Our data show that the complement pathway is involved in the MSK, revealing a new range of potential therapeutic targets and early diagnostic biomarkers.
... MAB194P antibody data suggested that an ~80 kDa form of OPN partially localised to the cis-/medial-Golgi apparatus of the secretory pathway, perhaps relating to the ER-Golgi intermediate compartment or trans-Golgi network. Golgi localisation of OPN has previously been observed in neurons and kidney tubule cells [33][34][35]. However, the MAB194P-detected OPN form was found in an apical localisation in confluent Ishikawa cells, almost completely separate from cis-/medial-Golgi, which may represent a trans-/post-Golgi compartment in polarised epithelial cells poised or engaged ...
... MAB194P antibody data suggested that an~80 kDa form of OPN partially localised to the cis-/medial-Golgi apparatus of the secretory pathway, perhaps relating to the ER-Golgi intermediate compartment or trans-Golgi network. Golgi localisation of OPN has previously been observed in neurons and kidney tubule cells [33][34][35]. However, the MAB194P-detected OPN form was found in an apical localisation in confluent Ishikawa cells, almost completely separate from cis-/medial-Golgi, which may represent a trans-/post-Golgi compartment in polarised epithelial cells poised or engaged in significant OPN secretion. ...
Article
Full-text available
At the onset of pregnancy, embryo implantation is initiated by interactions between the endometrial epithelium and the outer trophectoderm cells of the blastocyst. Osteopontin (OPN) is expressed in the endometrium and is implicated in attachment and signalling roles at the embryo–epithelium interface. We have characterised OPN in the human endometrial epithelial Ishikawa cell line using three different monoclonal antibodies, revealing at least nine distinct molecular weight forms and a novel secretory pathway localisation in the apical domain induced by cell organisation into a confluent epithelial layer. Mouse blastocysts co-cultured with Ishikawa cell layers served to model embryo apposition, attachment and initial invasion at implantation. Exogenous OPN attenuated initial, weak embryo attachment to Ishikawa cells but did not affect the attainment of stable attachment. Notably, exogenous OPN inhibited embryonic invasion of the underlying cell layer, and this corresponded with altered expression of transcription factors associated with differentiation from trophectoderm (Gata2) to invasive trophoblast giant cells (Hand1). These data demonstrate the complexity of endometrial OPN forms and suggest that OPN regulates embryonic invasion at implantation by signalling to the trophectoderm.
... We also found consistent evidence for increased OPN and subsequent intracellular uptake of pre-formed Ab 40 and Ab 42 fibrils by these GA-stimulated primary cultures. As expected, the cytokine OPN was mostly localized to macrophages within the major secretory pathway, the trans-Golgi network vesicles (Verhulst et al., 2002), indicating that it is constantly expressed and, perhaps, sorted for post-translation modifications prior to secretion. This pattern of intracellular OPN expression was different from that of the endosomal-lysosomal localization of Ab 40 and Ab 42 fibrils following phagocytosis. ...
Article
Full-text available
Osteopontin (OPN), a matricellular immunomodulatory cytokine highly expressed by bone marrow (BM)-derived myelomonocytes, regulates immune cell migration, communication, and response to brain injury. Enhanced cerebral recruitment of monocytes and macrophages by immunomodulation using glatiramer acetate (GA) or by peripheral blood enrichment with BM-derived CD115(+) monocytes (Mo(BM)) substantially curbs amyloid β-protein (Aβ) neuropathology and preserves cognitive function in murine models of Alzheimer's disease (ADtg mice). To elucidate the beneficial mechanisms of these immunomodulatory approaches in AD, we investigated the potential role of OPN in modulating macrophage-mediated Aβ clearance. Here, we found extensive OPN upregulation along with vascular and parenchymal Aβ deposit reduction in cortical and hippocampal regions of GA-immunized ADtg mice. Treatment combining GA with blood-grafted Mo(BM) (GA+Mo(BM)) further increased OPN levels surrounding residual Aβ plaques. In brains from AD patients and ADtg mice, OPN is also elevated and predominantly expressed by infiltrating GFP(+)- or Iba1(+)-CD45(high) monocyte-derived macrophages engaged in Aβ-plaque clearance. Following GA immunization, we detected a significant increase in subpopulations of inflammatory blood monocytes (CD115(+)CD11b(+)Ly6C(high)) expressing OPN, and subsequently, an elevated population of OPN(+)CD11b(+)Ly6C(+)CD45(high) monocyte-macrophages in brains of ADtg mice. Correlogram analyses indicate a strong linear correlation between cerebral OPN levels and macrophage infiltration, as well as a tight inverse relation between OPN and Aβ-plaque burden. In vitro studies corroborate in vivo findings by showing that GA directly upregulates OPN expression in BM-derived macrophages (MФ(BM)). OPN promotes a phenotype that is highly phagocytic (increased uptake of Aβ fibrils and associated scavenger receptors) and anti-inflammatory (altered cell morphology, iNOS, IL-10, and Aβ-degrading enzyme MMP-9). Inhibition of OPN expression in MФ(BM), either by siRNA, knockout (KO(OPN)), or minocycline, impairs uptake of Aβ fibrils and hinders GA's neuroprotective effects on macrophage immunological profile. Addition of human recombinant OPN reverses the impairment of Aβ phagocytosis in KO(OPN)-MФ(BM). This study demonstrates that OPN is an essential modulator of macrophage phenotype and their ability to clear pathogenic Aβ forms.
... Earlier reports, indeed, suggested that certain activities of MMP20 may contribute to the interstitial fibrosis resulting from increased matrix in aging kidney. [24][25][26][27][28][29][30][31][32][33][34][35][36][37] As speculated for other MMPs present in the kidney, 7 MMP20 may be involved in the homeostasis of normal tissue elements. Overall, a definitive role for MMP20 in renal function is yet to be described. ...
Article
Full-text available
We recently reported the expression of matrix metalloproteinase 20 (MMP20), hitherto thought to be tooth specific, in the metabolically active ductal epithelial cells of human salivary glands. Furthermore, our report indicated that MMP20 co-expressed and potentially interacts with dentin sialophosphoprotein (DSPP), a member of the small integrin-binding ligand N-linked glycoproteins (SIBLINGs). Our earlier reports have shown the co-expression of three MMPs, MMP2, MMP3, and MMP9, with specific members of the SIBLING family: bone sialoprotein, osteopontin, and dentin matrix protein 1, respectively. This study investigated the expression of MMP20 and verified its co-expression with DSPP in human and monkey kidney sections and human mixed renal cells by IHC, in situ proximity ligation assay, and immunofluorescence. Our results show that MMP20 is expressed in all segments of the human and monkey nephron with marked intensity in the proximal and distal tubules, and was absent in the glomeruli. Furthermore, MMP20 co-expressed with DSPP in the proximal, distal, and collecting tubules, and in mixed renal cells. Consistent with other SIBLING?MMP pairs, the DSPP?MMP20 pair may play a role in the normal turnover of cell surface proteins and/or repair of pericellular matrix proteins of the basement membranes in the metabolically active duct epithelial system of the nephrons.
... A cell culture system of primary human tubular kidney cells has been developed in our laboratory. The in vitro model was characterized extensively both at the physiological and pathophysiological level and evidence was presented for these cultures to consistently mimic the most important physiological characteristics of molecular uptake/transport by the tubular epithelium in vivo [19][20][21][22][23]. As we previously described, these cultures show both fluid-phase and receptor-mediated endocytotic uptake of molecules [22;24]. ...
Article
Full-text available
Zoledronic acid, a highly potent nitrogen-containing bisphosphonate used for the treatment of pathological bone loss, is excreted unmetabolized via the kidney if not bound to the bone. In cancer patients receiving high doses of the compound renal excretion may be associated with acute tubular necrosis. The question of how zoledronic acid is internalized by renal tubular cells has not been answered until now. In the current work, using a primary human tubular cell culture system, the pathway of cellular uptake of zoledronic acid (fluorescently/radiolabeled) and its cytotoxicity were investigated. Previous studies in our laboratory have shown that this primary cell culture model consistently mimics the physiological characteristics of molecular uptake/transport of the epithelium in vivo. Zoledronic acid was found to be taken up by tubular cells via fluid-phase-endocytosis (from apical and basolateral side) as evidenced by its co-localization with dextran. Cellular uptake and the resulting intracellular level was twice as high from the apical side compared to the basolateral side. Furthermore, the intracellular zoledronic acid level was found to be dependent on the administered concentration and not saturable. Cytotoxic effects however, were only seen at higher administration doses and/or after longer incubation times. Although zoledronic acid is taken up by tubular cells, no net tubular transport could be measured. It is concluded that fluid-phase-endocytosis of zoledronic acid and cellular accumulation at high doses may be responsible for the acute tubular necrosis observed in some cancer patients receiving high doses of the compound.
... 15,[17][18][19] Marked urinary excretion of complement components in severe preeclampsia 20 suggests that complement-mediated kidney injury is a key feature of disease. To map out potential sites of complement-mediated kidney injury in preeclampsia, we sought to measure a panel of urinary biomarkers linked to specific regions of the nephron [21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36] (Figure 1), among pregnant women with and without preeclampsia. ...
... In this same cohort of subjects, we recently reported that urinary excretion of complement components was increased in severe preeclampsia. 20 Thus, we investigated correlations between these previously measured complement markers (C3a, C5a, and C5b-9) and the kidney markers measured in [33][34][35] and uromodulin (UMOD). 33,36 this analysis. ...
Article
Full-text available
Kidney injury with proteinuria is a characteristic feature of preeclampsia, yet the nature of injury in specific regions of the nephron is incompletely understood. Our study aimed to use existing urinary biomarkers to describe the pattern of kidney injury and proteinuria in pregnancies affected by severe preeclampsia. We performed a case-control study of pregnant women from Brigham and Women's Hospital from 2012 to 2013. We matched cases of severe preeclampsia (n=25) 1:1 by parity and gestational age to 2 control groups with and without chronic hypertension. Urinary levels of kidney injury molecule-1 and complement components (C3a, C5a, and C5b-9) were measured by enzyme-linked immunosorbent assay, and other markers (albumin, β2 microglobulin, cystatin C, epithelial growth factor, neutrophil gelatinase-associated lipocalin, osteopontin, and uromodulin) were measured simultaneously with a multiplex electrochemiluminescence assay. Median values between groups were compared with the Wilcoxon signed-rank test and correlations with Spearman correlation coefficient. Analysis of urinary markers revealed higher excretion of albumin and kidney injury molecule-1 and lower excretion of neutrophil gelatinase-associated lipocalin and epithelial growth factor in severe preeclampsia compared with chronic hypertension and healthy controls. Among subjects with severe preeclampsia, urinary excretion of complement activation products correlated most closely with kidney injury molecule-1, a specific marker of proximal tubule injury (C5a: r=0.60; P=0.001; and C5b-9: r=0.75; P<0.0001). Taken together, we describe a pattern of kidney injury in severe preeclampsia that is characterized by glomerular impairment and complement-mediated inflammation and injury, possibly localized to the proximal tubule in association with kidney injury molecule-1.
... Therefore, osteopontin expression was also independent of VHL genetic status. [17] 4 Discussion ...
Article
Background: Von Hippel-Lindau (VHL) tumour suppressor gene inactivation is associated with clear cell renal cell carcinoma (CCRCC) development. The VHL protein (pVHL) has been proposed to regulate the expression of several proteins including Hypoxia Inducible Factor-α (HIF-α), carbonic anhydrase (CA)IX, heterogeneous nuclear ribonucleoprotein (hnRNP)A2/B1 and osteopontin. pVHL has been characterized in vitro, however, clinical studies are limited. We evaluated the impact of VHL genetic alterations on the expression of several pVHL protein targets in paired normal and tumor tissue. Methods: The VHL gene was sequenced in 23 CCRCC patients and VHL transcript levels were evaluated by Real-Time RT-PCR. Expression of pVHL's protein targets were determined by Western blotting in 17 paired patient samples. Results: VHL genetic alterations were identified in 43.5% (10/23) of CCRCCs. HIF-1α, HIF-2α and CAIX were up-regulated in 88.2% (15/17), 100% (17/17) and 88.2% (15/17) of tumors respectively and their expression is independent of VHL status. hnRNP A2/B1 and osteopontin expression was variable in CCRCCs and had no association with VHL genetic status. Conclusion: As expression of these proposed pVHL targets can be achieved independently of VHL mutation (and possibly by hypoxia alone), this data suggests that other pVHL targets may be more crucial in renal carcinogenesis.